Alimera Sciences Reports Fourth Quarter And Full Year 2013 Financial Results
[PR Newswire] – ATLANTA, Feb. 27, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic … more
View todays social media effects on ALIM
View the latest stocks trending across Twitter. Click to view dashboard